Tandem Diabetes Care, Inc. (TNDM) Total liabilities 2016–2025
Tandem Diabetes Care, Inc. (TNDM) total liabilities at each fiscal year-end, per SEC filings.
$725.9MFY2025 · since FY2016: $118.3M → $725.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $725.9M | +3.0% |
| FY2024 | $704.6M | +10.3% |
| FY2023 | $639.0M | +4.3% |
| FY2022 | $612.8M | +29.8% |
| FY2021 | $472.0M | +34.8% |
| FY2020 | $350.1M | +167.0% |
| FY2019 | $131.1M | +74.8% |
| FY2018 | $75.0M | -39.7% |
| FY2017 | $124.5M | +5.2% |
| FY2016 | $118.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More TNDM financial trends
TNDM RevenueTNDM Net incomeTNDM Net marginTNDM Gross profitTNDM Gross marginTNDM Operating incomeTNDM Operating marginTNDM Operating cash flowTNDM Free cash flowTNDM Capital expendituresTNDM Return on equityTNDM Stock buybacksTNDM Dividends paidTNDM Total assetsTNDM Shareholders’ equityTNDM overview →